Skip to main content

Samantha Thomas

Biostatistician, Principal
Biostatistics & Bioinformatics
DUMC 2717, Durham, NC 27710
2424 Erwin Road, 8039 Hock 1 Box 2717, Durham, NC 27710

Overview


Samantha is the manager of the Duke Cancer Institute (DCI) Biostatistics Shared Resource. Collaboratively, she primarily works with physicians in DCI, specifically in research of Endocrine Neoplasia and Breast Cancer. She is also the director of the Biostatistics, Epidemiology, Research, and Design Methods (BERD) Core Training and Internship Program (BCTIP). Her professional experience involves study design, analysis, and reporting of clinical trials and observational studies. Her specific areas of interest include training of collaborative biostatisticians, modeling of non-linear associations, and application of partitioning analyses to identify homogeneous patient groups.

Office Hours


DCI members who are interested in collaborating with a biostatistician should contact Samantha directly, or the Director of the DCI Biostatistics Shared Resource, Donna Niedzwiecki.

Current Appointments & Affiliations


Recent Publications


Exploring actionable targets to address disparities in thyroid cancer survival: A study of patients with aggressive variants of papillary thyroid cancer.

Journal Article Am J Surg · May 20, 2025 BACKGROUND: Despite compromised survival, disparities studies on aggressive variants of papillary thyroid cancer (PTC) are sparse. METHODS: Using the NCDB (2004-20), adult Non-Hispanic Whites (NHW), Non-Hispanic Asians or Pacific Islanders (NHAPI), Hispani ... Full text Link to item Cite

Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.

Journal Article JCO Clin Cancer Inform · March 2025 PURPOSE: Guidelines recommend omission of sentinel lymph node biopsy (SLNB) for axillary staging in select patients age 70 years and older with early-stage estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 neu-negative (HER2-) inva ... Full text Link to item Cite
View All Publications

Recent Grants


Planning grant for Take Off Pounds Sensibly (TOPS) for African American (AA) Cancer Survivors

ResearchBiostatistician III · Awarded by National Institutes of Health · 2024 - 2027

Defining Actionable Opportunities in Malignant Phyllodes via Genomic Profiling

ResearchBiostatistician · Awarded by Food and Drug Administration · 2024 - 2027

View All Grants

External Links


LinkedIN